Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Notch1 receptor as a marker of lymph node metastases in papillary thyroid cancer.

Cancer science - 1 Feb 2012

Park Hyung Seok, Jung Chan-Kwon, Lee Sung Hak, Chae Byung Joo, Lim Dong Jun, Park Woo Chan, Song Byung Joo, Kim Jeong Soo, Jung Sang Seol, Bae Ja-Seong

Abstract excerpt

Notch functions as an oncogene or tumor suppressor according to the type of malignancy, and the BRAF(V600E) mutation is commonly observed in thyroid cancer. However, the role of Notch and BRAF(V600E) in papillary thyroid cancer (PTC) is unclear. This study sought to elucidate the clinicopathological characteristics in patients with PTC regarding the expression of Notch1/Notch3 receptors and BRAF(V600E) mutation....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Carcinoma, Papillary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymph Nodes

Share to Lymphatic Metastasis

Share to Receptor, Notch1

Share to Receptor, Notch3

Share to Receptors, Notch

Share to Thyroid Cancer, Papillary

Source

Identifiers

PMID: 22118425
DOI: 10.1111/j.1349-7006.2011.02161.x

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Notch1 receptor as a marker of lymph node metastases in papillary thyroid cancer.PMID 22118425Read ↗

Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation.Semantic proximity Read ↗

Integrating BRAFV600E mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma.Semantic proximity Read ↗

BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.Semantic proximity Read ↗

BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid <or=1 cm and their paired lymph node metastases.Semantic proximity Read ↗

An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation.Semantic proximity Read ↗

BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma.Semantic proximity Read ↗

[The clinical significance of Delphian lymph node metastasis in papillary thyroid cancer].Semantic proximity Read ↗

Correlation between the BRAF V600E mutation status and the clinicopathologic features of papillary thyroid carcinoma.Semantic proximity Read ↗

Incidence and Clinical Significance of Delphian Lymph Node Metastasis in Unilateral Papillary Thyroid CarcinomaSemantic proximity Read ↗

Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: A systematic review and meta-analysis.Semantic proximity Read ↗

Is BRAFV600E mutation a marker for central nodal metastasis in small papillary thyroid carcinoma?Semantic proximity Read ↗

The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.